Maternal taurine supplementation in the late pregnant rat stimulates postnatal growth and induces obesity and insulin resistance in adult offspring

Journal of Physiology

Volumn 579, Issue 3, 2007, Pages 823-833

  Hultman, Karin ^a,c   Alexanderson, Camilla ^a   Mannerås, Louise ^a   Sandberg, Mats ^a   Holmäng, Agneta ^a   Jansson, Thomas ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF CINCINNATI   (United States)

^c SU/Sahlgrenska ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; INSULIN; LEPTIN; SOMATOMEDIN C; TAURINE;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; CATCH UP GROWTH; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAUTERINE GROWTH RETARDATION; LIPID STORAGE; MALE; MATERNAL TREATMENT; NONHUMAN; OBESITY; PATHOGENESIS; POSTNATAL GROWTH; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SPRAGUE DAWLEY RAT; THIRD TRIMESTER PREGNANCY; UTERINE TUBE LIGATION; VITAMIN SUPPLEMENTATION; ADULT; ANIMAL TISSUE; BIRTH WEIGHT; FETUS; PROGENY; SUPPLEMENTATION;

ADIPOSE TISSUE; ANIMALS; ANIMALS, NEWBORN; BODY COMPOSITION; BODY WEIGHT; FEMALE; GESTATIONAL AGE; GLUCOSE CLAMP TECHNIQUE; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; LIPID METABOLISM; MATERNAL NUTRITION PHYSIOLOGY; OBESITY; PLACENTAL INSUFFICIENCY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; TAURINE;

EID: 33947098441     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.124610     Document Type: Article

References (39)

1. Alberti KG, Zimmet P & Shaw J (2006). Metabolic syndrome -a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23, 469-480.
2. Anuradha CV & Balakrishnan SD (1999). Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance. Can J Physiol Pharmacol 77, 749-754.
3. Barker DJ, Osmond C, Forsen TJ, Kajantie E & Eriksson JG (2005). Trajectories of growth among children who have coronary events as adults. N Engl J Med 353, 1802-1809.
4. Bernstein IGS (1996). Obstetrics. Intrauterine Growth Restriction. Churchill Livingstone, New York.
5. Bosello O & Zamboni M (2000). Visceral obesity and metabolic syndrome. Obesity Rev 1, 47-56.
6. Boujendar S, Arany E, Hill D, Remacle C & Reusens B (2003). Taurine supplementation of a low protein diet fed to rat dams normalizes the vascularization of the fetal endocrine pancreas. J Nutr 133, 2820-2825.
7. Cetin I, Corbetta C, Sereni LP, Marconi AM, Bozzetti P, Pardi G & Battaglia FC (1990). Umbilical amino acid concentrations in normal and growth-retarded fetuses sampled in utero by cordocentesis. Am J Obstet Gynecol 162, 253-261.
8. Cherif H, Reusens B, Ahn MT, Hoet JJ & Remacle C (1998). Effects of taurine on the insulin secretion of rat fetal islets from dams fed a low-protein diet. J Endocrinol 159, 341-348.
9. Dahlgren J, Nilsson C, Jennische E, Ho HP, Eriksson E, Niklasson A, Bjorntorp P, Albertsson Wikland K & Holmang A (2001). Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol Endocrinol Metab 281, E326-E334.
10. Desai M, Gayle D, Babu J & Ross MG (2005). Programmed obesity in intrauterine growth-restricted newborns: Modulation by newborn nutrition. Am J Physiol Regul Integr Comp Physiol 288, R91-R96.
11. Eriksson JG & Forsen TJ (2002). Childhood growth and coronary heart disease in later life. Ann Med 34, 157-161.
12. Forsen T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C & Barker D (2000). The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med 133, 176-182.
13. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C & Winter PD (1991). Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303, 1019-1022.
14. Hansen SH (2001). The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev 17, 330-346.
15. Hibbard JU, Pridjian G, Whitington PF & Moawad AH (1990). Taurine transport in the in vitro perfused human placenta. Pediatr Res 27, 80-84.
16. Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA & Gluckman PD (1997). Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 82, 402-406.
17. Holmang A, Svedberg J, Jennische E & Bjorntorp P (1990). Effects of testosterone on muscle insulin sensitivity and morphology in female rats. Am J Physiol Endocrinol Metab 259, E555-E560.
18. Hu JM, Rho JY, Suzuki M, Nishihara M & Takahashi M (2000). Effect of taurine in rat milk on the growth of offspring. J Vet Med Sci 62, 693-698.
19. Huxtable RJ (1992). Physiological actions of taurine. Physiol Rev 72, 101-163.
20. Ikuyama S, Okajima T, Kato K & Ibayashi H (1988). Effect of taurine on growth hormone and prolactin secretion in rats: Possible interaction with opioid peptidergic system. Life Sci 43, 807-812.
21. Jansson T & Lambert GW (1999). Effect of intrauterine growth restriction on blood pressure, glucose tolerance and sympathetic nervous system activity in the rat at 3-4 months of age. J Hypertens 17, 1239-1248.
22. Lindroth PMK (1979). High performance liquid chromatographic determination of subpicomole amounts of amino acids by precolumn fluorescence derivatization with o -phthaldialdehyde. Anal Chem 51, 1667-1674.
23. Mantovani J & DeVivo DC (1979). Effects of taurine on seizures and growth hormone release in epileptic patients. Arch Neurol 36, 672-674.
24. Merezak S, Reusens B, Renard A, Goosse K, Kalbe L, Ahn MT, Tamarit-Rodriguez J & Remacle C (2004). Effect of maternal low-protein diet and taurine on the vulnerability of adult Wistar rat islets to cytokines. Diabetologia 47, 669-675.
25. Murakami S, Kondo Y, Toda Y, Kitajima H, Kameo K, Sakono M & Fukuda N (2002). Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine. Life Sci 70, 2355-2366.
26. Nakaya Y, Minami A, Harada N, Sakamoto S, Niwa Y & Ohnaka M (2000). Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. Am J Clin Nutr 71, 54-58.
27. Nilsson C, Niklasson M, Eriksson E, Bjorntorp P & Holmang A (1998). Imprinting of female offspring with testosterone results in insulin resistance and changes in body fat distribution at adult age in rats. J Clin Invest 101, 74-78.
28. Norberg S, Powell TL & Jansson T (1998). Intrauterine growth restriction is associated with a reduced activity of placental taurine transporters. Pediatr Res 44, 233-238.
29. Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A & Seckl JR (1998). Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest 101, 2174-2181.
30. Ong KK, Petry CJ, Emmett PM, Sandhu MS, Kiess W, Hales CN, Ness AR & Dunger DB (2004). Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia 47, 1064-1070.
31. Ozanne SE, Jensen CB, Tingey KJ, Storgaard H, Madsbad S & Vaag AA (2005). Low birthweight is associated with specific changes in muscle insulin-signalling protein expression. Diabetologia 48, 547-552.
32. Phipps K, Barker DJ, Hales CN, Fall CH, Osmond C & Clark PM (1993). Fetal growth and impaired glucose tolerance in men and women. Diabetologia 36, 225-228.
33. Ramamoorthy S, Leibach FH, Mahesh VB, Han H, Yang-Feng T, Blakely RD & Ganapathy V (1994). Functional characterization and chromosomal localization of a cloned taurine transporter from human placenta. Biochem J 300, 893-900.
34. Randle PJ (1998). Regulatory interactions between lipids and carbohydrates: The glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14, 263-283.
35. Sandberg M, Butcher SP & Hagberg H (1986). Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: In vivo dialysis of the rat hippocampus. J Neurochem 47, 178-184.
36. Simmons RA, Templeton LJ & Gertz SJ (2001). Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 50, 2279-2286.
37. Terrettaz J & Jeanrenaud B (1983). In vivo hepatic and peripheral insulin resistance in genetically obese (fa/fa) rats. Endocrinology 112, 1346-1351.
38. Wannamethee SG, Tchernova J, Whincup P, Lowe GD, Kelly A, Rumley A, Wallace AM & Sattar N (2006). Plasma leptin: Associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis (in press).
39. Zimmet P, Alberti KG & Shaw J (2001). Global and societal implications of the diabetes epidemic. Nature 414, 782-787.